Inventage Lab will participate in PODD: Partnership Opportunities in Drug Delivery 2026, taking place October 29–30, 2026 at the Sheraton Boston Hotel in Boston, USA — marking the company's second consecutive year at the conference.
Now in its 16th year, PODD is a leading global partnering conference in drug delivery, hosted by Questex. The event convenes over 1,000 leaders from pharma, biotech, drug delivery, academia, and the investment community, featuring more than 150 sessions, dedicated technology presentation tracks, and one-to-one partnering meetings that translate delivery innovation into business collaboration.
Inventage Lab is a clinical-stage biotech developing next-generation drug delivery platforms based on its proprietary microfluidic technology. At PODD 2026, the company will focus on DrugFluidic®, its long-acting injectable (LAI) platform for small molecules and peptides, and BioFluidic™, its platform for subcutaneous (SC) formulation optimization of antibody and protein therapeutics.
In addition to exhibiting, Inventage Lab will deliver a presentation in the Injectable Formulations & Technologies track of the Drug Delivery Technology Presentation Tracks.
Speaking Session
Visitors are welcome at the Inventage Lab booth (Booth #525) for technical discussions throughout the conference. The company will actively pursue co-development, and licensing partnership opportunities through one-to-one partnering meetings, and welcomes meeting requests from pharmaceutical and biotech companies interested in global partnering.
